Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed

Amgen (AMGN) announced the retirement of Peter Griffith, who has served as the company’s executive vice president and CFO since 2020. The company also announced that Thomas Dittrich will return to Amgen as executive vice president on July 1 and succeed Griffith as CFO effective September 1. Dittrich, who previously held senior finance roles at Amgen, brings more than 30 years of international leadership experience to the company, along with a strong understanding of the biopharmaceutical industry and consumer-focused healthcare markets. Most recently, he served as CFO of Galderma. Prior to that, he served as chief financial officer at both Shire and Sulzer. Dittrich will oversee all aspects of Amgen’s financial operations. Griffith will remain with the company into January 2027 to support a seamless transition.